More Articles
Circadian rhythms in heart cells can affect heart function throughout the day, possibly explaining why shift workers are so susceptible to cardiac issues, …
Continuous heart rhythm monitoring can identify when patients face a higher risk of atrial fibrillation (AFib) or ischemic stroke, according to a new analysis published in JAMA Cardiology.
…
Chronic obstructive pulmonary disease (COPD) is common among atrial fibrillation (AFib) patients and associated with worse clinical outcomes, according to new…
Cardialen, a Minnesota-based healthcare technology company, has received a $3 million grant from the National Institutes of Health to continue developing a new low-energy therapy for atrial fibrillation (AFib).
…
Medtronic and Mpirik are collaborating on a new pilot program focused on improving care for patients at risk of sudden cardiac arrest (SCA).
The two companies hope to address disparities in care for…
A healthy sleep pattern can help someone lower their risk of atrial fibrillation (AFib) and bradyarrhythmia, according to new data published in the Journal of the…
Researchers have developed a new risk score capable of identifying when atrial fibrillation (AFib) patients who visit the emergency department (ED) are at an elevated risk of new-onset heart failure…
Delayed peridevice leak (PDL) is present in more than 10% of patients who undergo left atrial appendage closure (LAAC) with Boston Scientific’s Watchman devices (WD), according to new findings published in JACC: Clinical…
Patients with atrial fibrillation (AFib) who take direct oral anticoagulants (DOAC) and warfarin are at a similar risk of developing dementia, according to new data published in Stroke.…
People living with human immunodeficiency virus (HIV) face an elevated risk of sudden cardiac death, according to new…
Continuous heart rhythm monitoring with an implantable loop recorder (ILC) leads to much higher rates of atrial fibrillation (AFib) detection, according to new findings published in The Lancet. However, researchers emphasized…
Researchers have compared the safety and effectiveness of Abbott’s Amplatzer Amulet left atrial appendage (LAA) occluder with Boston Scientific’s first-generation Watchman LAA occluder, publishing their findings in Circulation…
Exercise can help patients with atrial fibrillation (AFib) maintain a normal heart rhythm and lower the prevalence of serious symptoms, according to new research presented at the ESC Congress 2021.…
Trouble breathing was the most common symptom reported by patients who experienced cardiac arrest, while 1 in 10 patients reported their arrest to emergency medical services 24-hours before it occurred,…
More than two-thirds of atrial fibrillation (AFib) patients who take oral anticoagulant (OAC) medication underestimate their risk of a major bleeding episode, according to new data published…
Women face a heightened risk of poor in-hospital outcomes after left atrial appendage occlusion (LAAO), according to a new analysis published in JAMA Cardiology.
The study’s authors examined…
When treating atrial fibrillation (AFib), catheter ablation is associated with better outcomes — including fewer hospitalizations — than antiarrhythmic drugs (AADs), according to a new meta-analysis published in Circulation:…
Night shift workers are at an elevated risk of developing atrial fibrillation (AFib), according to new research published in the European Heart Journal. They also face a greater risk of coronary heart…
Abbott has gained FDA approval for its Amplatzer Amulet left atrial appendage (LAA) occluder to treat atrial fibrillation (AFib) patients at a high risk of stroke.
The device was designed to “…
The FDA has announced that Boston Scientific is recalling 48,000 INGENIO pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps).
The recall is due to potential issues when the devices…
When implemented early on, rhythm control therapy utilizing arrhythmic drugs or atrial fibrillation (AFib) ablation decreases cardiovascular events in patients with heart failure, according to new data…